WuXi Biologics (Cayman) Inc.
WXIBF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $2,339 | $3,335 | $1,499 | $1,700 |
| Dep. & Amort. | $854 | $653 | $784 | $585 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $469 | $525 | $690 | $637 |
| Change in WC | $0 | -$801 | $0 | -$448 |
| Other Non-Cash | -$1,856 | $202 | -$1,671 | -$140 |
| Operating Cash Flow | $1,807 | $3,915 | $1,302 | $2,334 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$1,900 | -$2,062 | -$1,867 | -$2,023 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | -$11,429 | $0 | -$7,542 |
| Inv. Sales/Matur. | $0 | $10,893 | $0 | $7,819 |
| Other Inv. Act. | $1,362 | -$961 | $1,485 | $131 |
| Investing Cash Flow | -$538 | -$3,559 | -$383 | -$1,614 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $2 | $490 | -$70 | -$409 |
| Stock Issued | $0 | $19 | $0 | $13 |
| Stock Repurch. | -$1,032 | -$532 | -$1,234 | -$458 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$56 | -$1,253 | -$172 | $3,004 |
| Financing Cash Flow | -$1,086 | -$1,275 | -$1,476 | $2,149 |
| Forex Effect | -$23 | $44 | $40 | -$63 |
| Net Chg. in Cash | $8,439 | $8,537 | -$258 | $3,275 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $0 | -$258 | $0 | $6,395 |
| End Cash | $8,439 | $8,279 | -$258 | $9,670 |
| Free Cash Flow | -$94 | $1,853 | -$565 | $219 |